Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Clinical trial NCT02633059 · COMPLETED
Trial details
- NCT number
- NCT02633059
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-30
- Primary completion
- 2021-01-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.